# FDA 483 - Fayz A. Hudefi, M.D. - April 21, 2023

Source: https://www.keypedia.com/records/483/fayz-a-hudefi-md/4593b78d-8dfb-4c15-8912-201a6f437081

> FDA 483 for Fayz A. Hudefi, M.D. on April 21, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Fayz A. Hudefi, M.D.
- Inspection Date: 2023-04-21
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Fayz A. Hudefi, M.D. in Bentonville, AR, revealed significant deficiencies in the conduct of clinical investigations. The firm failed to adhere to investigational plans, exhibiting issues with subject identification, data integrity, and protocol compliance within the residential unit. Additionally, the clinical investigator did not report non-serious adverse events to the sponsor in a timely manner.

## Related Officers

- [CSO](https://www.keypedia.com/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.keypedia.com/companies/fayz-a-hudefi-md/01861255-1c5d-4ec4-9bf9-f60e5ecfe54d

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab